Urgo laboratories

What Urgo laboratories does

Urgo Laboratories (legal entity: Laboratoires Urgo Healthcare) is a privately held French consumer healthcare company founded in 1958 and headquartered in Chenôve, France. The company develops, manufactures, and sells over-the-counter wound care, first aid, dermatological, foot care, and pain management products under the URGO brand and a portfolio of proprietary technology platforms including Filmogel® (liquid film-forming plasters), Filmomousse® (foaming emulsion), Filmocrème® (lightweight emulsion), Hydrocolloïde, Lipido-colloïde, TENS, medical-grade honey, Syndet purifiant, and micro-needling delivery systems. Product categories span burns, blisters, cold sores, warts, nail fungus, acne, dry/cracked skin, muscle and joint pain, and women's health, with multiple recent launches including a full acne-prone skin line and a licensed Harry Potter-themed children's plaster range.

Urgo operates a direct-to-consumer go-to-market, distributing through its own e-commerce platform (urgo.fr) and through France-wide pharmacy and retail channels. Revenue is generated through one-time product sales of OTC medical devices and consumer health SKUs; no subscription, licensing, or enterprise B2B revenue streams are disclosed. The company employs between 1,001 and 5,000 people, operates exclusively in the French market, and is not publicly listed. No parent company, external investors, or funding rounds are disclosed in the available data, indicating a likely independent or family-owned ownership structure. Strategic activity in 2025-2026 has been concentrated in product expansion (acne skincare line, silicone bandage generation, foot care extension, Filmocrème platform) and one consumer-facing licensing partnership (Harry Potter plasters), with no M&A, geographic expansion, or restructuring events recorded.

Name

Urgo laboratories

Legal name

Laboratoires Urgo Healthcare

Website

https://urgo.com

Company type

Private

Founded year

1958

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Urgo Laboratories is a French private consumer healthcare company founded in 1958 that develops and sells OTC wound care, first aid, dermatological, foot care, and pain management products under proprietary technologies such as Filmogel®, distributing via pharmacy retail and D2C e-commerce across France.

Ownership category

akta.pro rank

Headquarters

HQ city

Chenôve

HQ country

France

HQ region

Europe

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Consumer Healthcare Products: Sale of over-the-counter healthcare and wound care products including bandages, treatments for burns, blisters, cold sores, acne, foot care, and muscle pain. Products are sold through e-commerce and retail/pharmacy channels.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Urgo Laboratories (Laboratoires Urgo Healthcare) manufactures and sells over-the-counter consumer healthcare products for wound care, first aid, and dermatological treatments. Its portfolio covers treatments for burns, blisters, warts, nail fungus, cold sores, acne-prone skin, dry/cracked skin, muscle pain, and insect bites, delivered through proprietary technologies such as Filmogel®, Filmomousse®, Filmocrème®, hydrocolloid, lipido-colloid, TENS, medical honey, and micro-needling systems. Products are distributed directly to consumers through the urgo.fr e-commerce site and through pharmacy/retail channels in France.

Product overview

Urgo Laboratories (Laboratoires Urgo Healthcare) is a French healthcare company founded in 1958, specializing in wound care, first aid, and dermatological treatments. The product portfolio centers on proprietary technologies including Filmogel®, Filmomousse®, Filmocrème®, Hydrocolloïde, Lipido-colloïde, TENS, Miel médical, Syndet purifiant, and Micro-needling. The core product offerings span multiple categories: essential treatments for burns, warts, nail fungus and trauma, and foot care; first aid products for wound protection, dressing fixation, wound healing, oral care, insect bites, and antiseptics; pain management including muscle pain relief and joint/muscle support; and skin health products for dry/cracked skin, damaged skin, atopic skin, cold sores, and acne-prone skin. The recent expansion includes an acne-prone skin product line (Gamme Peau à tendance acnéique) featuring multiple delivery formats: URGO Filmogel® Boutons localisés, URGO Patch hydrocolloïde micro-needling, URGO Syndet Purifiant, and URGO Concentré Sébo-régulateur.

Differentiator

Problem solved

Functional benefit

Products and services

• URGO Filmogel® Boutons localisés Filmogel® technology product for treating localized breakouts on acne-prone skin; forms a protective film over pimples for French consumer market.
• URGO Patch hydrocolloïde micro-needling Hydrocolloid patch combined with micro-needling technology for treating acne-prone skin; creates micro-channels for enhanced active absorption.
• URGO Syndet Purifiant

Quantifiable outcome

• 4.5/5 rating based on 866 customer evaluations for URGO Filmogel Mycose product
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

One partnership is on record.

• Google Inc.minorOthersGoogle Inc. serves as a partner for web analytics (Google Analytics) and advertising services (Google Ads, Google AdWords Pixel) on the urgo.fr website, providing audience measurement and performance advertising capabilities. This is a vendor/technology partnership for digital marketing operations rather than a core business partnership.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Beiersdorf: Owner of Hansaplast/Elastoplast, the leading European adhesive bandage brand, and Eucerin in dermo-cosmetics. Directly competes with Urgo across wound care plasters and dermatology/skincare categories in France and broader Europe.
• Bayer Consumer Health (Bepanthen): Bayer's Bepanthen/Bepanthol line covers wound healing creams, antiseptics, and sensitive-skin products — directly competing with Urgo in first aid and minor wound treatment categories across Europe.
• La Roche-Posay (L'Oréal): French dermo-cosmetic brand within L'Oréal focused on sensitive, acne-prone, and atopic skincare. Directly comparable to Urgo's acne range (Filmocrème, Syndet Purifiant, sébo-régulateur) and broader dermatology franchise.
• Hartmann Group: German specialist in wound management (hydrocolloid, foam, and advanced dressings) with a wide pharmacy channel. Comparable to Urgo on professional wound care technologies (Lipido-colloïde, Hydrocolloïde).

Broad incumbents

• ConvaTec: Global wound care company with hydrocolloid and advanced dressing lines. Technology overlap with Urgo's hydrocolloïde platform and wound care franchise.
• 3M Health Care: Diversified medical and consumer health business with significant wound care and skin-treatment product lines. Adjacent competitor to Urgo in advanced wound care technology and OTC-format products.
• Coloplast: Danish specialist in wound and skin care (including hydrocolloid-based dressings). Comparable technology overlap with Urgo's hydrocolloïde platform, though Coloplast is more focused on chronic/stoma care.
• Johnson & Johnson (Band-Aid / Neutrogena): Band-Aid is the global category leader in adhesive bandages and J&J's Neutrogena covers acne-prone skincare. Overlaps directly with Urgo's wound care and acne-line extensions, though J&J operates as a much larger diversified healthcare incumbent.

Peers

• Pierre Fabre: French pharmaceutical and dermo-cosmetic group with dermatology brands (Avène, Ducray, A-Derma) plus OTC ranges. Closest French-headquartered peer to Urgo, competing across dermatology, foot care, and OTC channels in pharmacies.

Others

• Urgo Medical / SantéDom (related entity): Separately branded Urgo entity serving healthcare professionals in advanced wound care. Adjacent ecosystem participant sharing the Urgo brand, technology platforms, and parent group, though serving a different channel (clinicians/hospitals vs. consumer).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Urgo laboratories